Compare IDEXX Laboratories, Inc. (IDXX) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs abrdn Physical Palladium Shares ETF — how do they compare? IDEXX Laboratories, Inc. trades at $553.81 (market cap $44.48B), while abrdn Physical Palladium Shares ETF trades at $23.31. Which is the better fit depends on your goals.
| IDXX | PALL | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $766.68 | $37.18 |
52-Week Low | $520.87 | $19.96 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
PALL (abrdn Physical Palladium Shares ETF) trades at $22.80, up 0.44% with a bearish technical signal from moving averages. Recent news highlights palladium's underperformance versus other precious metals, though some analysts see current price weakness as a buying opportunity. The ETF underwent a 5-for-1 forward share split on May 18, 2026, which adjusted share count without changing the underlying value.
The outlook for PALL hinges on palladium's supply-demand dynamics and industrial usage. While technical indicators suggest near-term pressure, fundamental factors like supply constraints and potential demand recovery could support prices. Key risks include Federal Reserve policy impacts and global economic conditions affecting industrial demand for palladium.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About abrdn Physical Palladium Shares ETF
PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →
